Search Results - "Dillon, John"

The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations by Lazarus, Jeffrey V, Safreed-Harmon, Kelly, Thursz, Mark R, Dillon, John F, El-Sayed, Manal H, Elsharkawy, Ahmed M, Hatzakis, Angelos, Jadoul, Michel, Prestileo, Tullio, Razavi, Homie, Rockstroh, Jürgen K, Wiktor, Stefan Z, Colombo, Massimo

“…The introduction of efficacious new hepatitis C virus (HCV) treatments galvanized the World Health Organization to define ambitious targets for eliminating HCV…”
Get more information

Guidelines on the management of abnormal liver blood tests by Newsome, Philip N, Cramb, Rob, Davison, Suzanne M, Dillon, John F, Foulerton, Mark, Godfrey, Edmund M, Hall, Richard, Harrower, Ulrike, Hudson, Mark, Langford, Andrew, Mackie, Anne, Mitchell-Thain, Robert, Sennett, Karen, Sheron, Nicholas C, Verne, Julia, Walmsley, Martine, Yeoman, Andrew

“…These updated guidelines on the management of abnormal liver blood tests have been commissioned by the Clinical Services and Standards Committee (CSSC) of the…”
Get more information

Gamma‐Glutamyl Transferase (γ‐GT) – an old dog with new tricks? by Brennan, Paul N., Dillon, John F., Tapper, Elliot B.

“…Gamma‐Glutamyl Transferase (γGT) is a key transferase involved in the transpeptidation of functional gamma‐glutamyl groups to various receptor moieties. It…”
Get full text

DOT-C: A cluster randomised feasibility trial evaluating directly observed anti-HCV therapy in a population receiving opioid substitute therapy from community pharmacy by Radley, Andrew, Tait, Jan, Dillon, John F.

“…Direct-acting antiviral therapy (DAAs) for hepatitis C infection (HCV) have a much smaller burden of treatment than interferon-based regimes, require less…”
Get full text

Effectiveness of the use of implementation intentions on reduction of substance use: A meta-analysis by Malaguti, Amy, Ciocanel, Oana, Sani, Fabio, Dillon, John F., Eriksen, Ann, Power, Kevin

“…•Small significant effect of implementation intentions on reducing alcohol use, g = 0.31 (95 % CI: 0.21, 0.42), p < .001.•Small significant effect of…”
Get full text

Accuracy of Non-Invasive Imaging Techniques for the Diagnosis of MASH in Patients With MASLD: A Systematic Review by Cathcart, Jennifer, Barrett, Rachael, Bowness, James S, Mukhopadhya, Ashis, Lynch, Ruairi, Dillon, John F

“…Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing public health problem. The secondary stage in MASLD is steatohepatitis (MASH),…”
Get full text

Cost-Effectiveness of Treating Hepatitis C in Clients on Opioid Agonist Therapy in Community Pharmacies Compared to Primary Healthcare in Australia by Ginnane, Joshua F, Scott, Nick, Radley, Andrew, Dillon, John F, Hellard, Margaret, Doyle, Joseph

“…Meeting the World Health Organisation 2030 target of treating 80% of people with hepatitis C virus (HCV) in Australia requires accessible testing and treatment…”
Get full text

A systematic review and meta-analysis of community and primary-care-based hepatitis C testing and treatment services that employ direct acting antiviral drug treatments by Radley, Andrew, Robinson, Emma, Aspinall, Esther J, Angus, Kathryn, Tan, Lex, Dillon, John F

“…Direct Acting Antiviral (DAAs) drugs have a much lower burden of treatment and monitoring requirements than regimens containing interferon and ribavirin, and a…”
Get full text

Nonalcoholic steatohepatitis and mechanisms by which it is ameliorated by activation of the CNC-bZIP transcription factor Nrf2 by Bathish, Boushra, Robertson, Holly, Dillon, John F., Dinkova-Kostova, Albena T., Hayes, John D.

“…Non-alcoholic steatohepatitis (NASH) represents a global health concern. It is characterised by fatty liver, hepatocyte cell death and inflammation, which are…”
Get full text

Transformation of identity in substance use as a pathway to recovery and the potential of treatment for hepatitis C: a systematic review by Donaldson, Sarah R., Radley, Andrew, Dillon, John F.

“…Background and aim People who inject drugs are at high risk of contracting hepatitis C (HCV). The introduction of direct acting antiviral (DAA) drugs to treat…”
Get full text

Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale‐up in the age of direct‐acting antivirals by Martin, Natasha K., Vickerman, Peter, Grebely, Jason, Hellard, Margaret, Hutchinson, Sharon J., Lima, Viviane D., Foster, Graham R., Dillon, John F., Goldberg, David J., Dore, Gregory J., Hickman, Matthew

“…Substantial reductions in hepatitis C virus (HCV) prevalence among people who inject drugs (PWID) cannot be achieved by harm reduction interventions such as…”
Get full text

Increased risk of chronic kidney disease and mortality in a cohort of people diagnosed with metabolic dysfunction associated steatotic liver disease with hepatic fibrosis by Gurun, Marc, Brennan, Paul, Handjiev, Sava, Khatib, Aseil, Leith, Damien, Dillon, John F, Byrne, Christopher J

“…Metabolic dysfunction associated steatotic liver disease (MASLD) increases the risk of incident chronic kidney disease (CKD). However, the relative risk of CKD…”
Get full text

Reactive Oxygen Species and Oxidative Stress in the Pathogenesis of MAFLD by Clare, Kathleen, Dillon, John F., Brennan, Paul N.

“…The pathogenesis of metabolic-associated fatty liver disease (MAFLD) is complex and thought to be dependent on multiple parallel hits on a background of…”
Get full text

Thrombocytosis and abnormal liver enzymes: A trigger for investigation of underlying malignancy by Gold, Lucy C, Macpherson, Iain, Nobes, Jennifer H, Dow, Eleanor, Furrie, Elizabeth, Jamieson, Scott, Dillon, John F

“…Thrombocytosis is often an incidental finding in primary care with a range of causes. Despite evidence of a strong association between thrombocytosis and…”
Get full text

Systematic review: the role of frailty in advanced chronic liver disease by Bowers, Sarah P, Brennan, Paul N, Dillon, John F

“…Frailty is a known predictor of outcome and mortality in patients undergoing liver transplantation. However, most patients remain unsuitable transplant…”
Get full text

Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis by Hajarizadeh, Behzad, Cunningham, Evan B., Valerio, Heather, Martinello, Marianne, Law, Matthew, Janjua, Naveed Z., Midgard, Håvard, Dalgard, Olav, Dillon, John, Hickman, Matthew, Bruneau, Julie, Dore, Gregory J., Grebely, Jason

“…HCV reinfection following successful treatment can compromise treatment outcomes. This systematic review assessed the rate of HCV reinfection following…”
Get full text

Determining the role for uric acid in non-alcoholic steatohepatitis development and the utility of urate metabolites in diagnosis: An opinion review by Brennan, Paul, Clare, Kathleen, George, Jacob, Dillon, John F

“…There has long been a recognised association between non-alcoholic fatty liver disease (NAFLD) and the composite aspects of the metabolic syndrome. Part of…”
Get full text

High response and re‐infection rates among people who inject drugs treated for hepatitis C in a community needle and syringe programme by Schulkind, Jasmine, Stephens, Brian, Ahmad, Farsana, Johnston, Linda, Hutchinson, Sharon, Thain, Donna, Ward, Zoe, Vickerman, Peter, Hickman, Matt, Dillon, John F.

“…Summary To achieve WHO hepatitis C virus (HCV) elimination targets by 2030, mathematical models suggest there needs to be significant scale‐up of treatment…”
Get full text

MAIT cells are activated during human viral infections by van Wilgenburg, Bonnie, Scherwitzl, Iris, Hutchinson, Edward C., Leng, Tianqi, Kurioka, Ayako, Kulicke, Corinna, de Lara, Catherine, Cole, Suzanne, Vasanawathana, Sirijitt, Limpitikul, Wannee, Malasit, Prida, Young, Duncan, Denney, Laura, Moore, Michael D., Fabris, Paolo, Giordani, Maria Teresa, Oo, Ye Htun, Laidlaw, Stephen M., Dustin, Lynn B., Ho, Ling-Pei, Thompson, Fiona M., Ramamurthy, Narayan, Mongkolsapaya, Juthathip, Willberg, Christian B., Screaton, Gavin R., Klenerman, Paul

“…Mucosal-associated invariant T (MAIT) cells are abundant in humans and recognize bacterial ligands. Here, we demonstrate that MAIT cells are also activated…”
Get full text

The effect of introducing point-of-care or dried blood spot analysis on the uptake of hepatitis C virus testing in high-risk populations: A systematic review of the literature by Coats, Josh T, Dillon, John F

“…Highlights • New testing methods for hepatitis C virus are needed to target high risk populations. • Dried blood spots and point of care testing both aim to…”
Get full text